ABTEC Stock Overview
Engages in the manufacture and sale of ingredients for cosmetic industry in Norway. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Aqua Bio Technology ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 2.10 |
| 52 Week High | NOK 7.56 |
| 52 Week Low | NOK 2.06 |
| Beta | 0.68 |
| 11 Month Change | -28.81% |
| 3 Month Change | -43.85% |
| 1 Year Change | -35.78% |
| 33 Year Change | -85.00% |
| 5 Year Change | -19.85% |
| Change since IPO | -98.79% |
Recent News & Updates
Shareholder Returns
| ABTEC | NO Chemicals | NO Market | |
|---|---|---|---|
| 7D | -12.5% | 2.6% | 3.1% |
| 1Y | -35.8% | -8.0% | 3.9% |
Return vs Industry: ABTEC underperformed the Norwegian Chemicals industry which returned -9.1% over the past year.
Return vs Market: ABTEC underperformed the Norwegian Market which returned 2.5% over the past year.
Price Volatility
| ABTEC volatility | |
|---|---|
| ABTEC Average Weekly Movement | 12.3% |
| Chemicals Industry Average Movement | 6.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in NO Market | 10.6% |
| 10% least volatile stocks in NO Market | 2.7% |
Stable Share Price: ABTEC's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: ABTEC's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 4 | Havard Lindstrom | aquabiotechnology.com |
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics.
Aqua Bio Technology ASA Fundamentals Summary
| ABTEC fundamental statistics | |
|---|---|
| Market cap | NOK 145.90m |
| Earnings (TTM) | -NOK 1.50m |
| Revenue (TTM) | NOK 13.82m |
10.6x
P/S Ratio-97.1x
P/E RatioIs ABTEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABTEC income statement (TTM) | |
|---|---|
| Revenue | NOK 13.82m |
| Cost of Revenue | NOK 4.50m |
| Gross Profit | NOK 9.32m |
| Other Expenses | NOK 10.82m |
| Earnings | -NOK 1.50m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | -0.022 |
| Gross Margin | 67.43% |
| Net Profit Margin | -10.88% |
| Debt/Equity Ratio | 264.7% |
How did ABTEC perform over the long term?
See historical performance and comparison